Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1-allergic asthma.
Scadding GK, McDonald M, Backer V, Scadding G, Bernal-Sprekelsen M, Conti DM, De Corso E, Diamant Z, Gray C, Hopkins C, Jesenak M, Johansen P, Kappen J, Mullol J, Price D, Quirce S, Reitsma S, Salmi S, Senior B, Thyssen JP, Wahn U, Hellings PW. Scadding GK, et al. Among authors: hopkins c. Front Allergy. 2024 Jan 30;4:1291185. doi: 10.3389/falgy.2023.1291185. eCollection 2023. Front Allergy. 2024. PMID: 38352244 Free PMC article. Review.
Pre-asthma: a useful concept? A EUFOREA paper. Part 2-late onset eosinophilic asthma.
Scadding GK, Gray C, Conti DM, McDonald M, Backer V, Scadding G, Bernal-Sprekelsen M, De Corso E, Diamant Z, Hopkins C, Jesenak M, Johansen P, Kappen J, Mullol J, Price D, Quirce S, Reitsma S, Toppila-Salmi S, Senior B, Thyssen JP, Wahn U, Hellings PW. Scadding GK, et al. Among authors: hopkins c. Front Allergy. 2024 May 15;5:1404735. doi: 10.3389/falgy.2024.1404735. eCollection 2024. Front Allergy. 2024. PMID: 38812719 Free PMC article. Review.
Real-world effectiveness of dupilumab in a European cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR).
Seys SF, Schneider S, de Kinderen J, Reitsma S, Cavaliere C, Tomazic PV, Morgenstern C, Mortuaire G, Wagenmann M, Bettio G, Ciofalo A, Diamant Z, Eckl-Dorna J, Fokkens WJ, Holzmeister C, Mariën G, Masieri S, Otten J, Scheckenbach K, Tu A, Bachert C; CHRINOSOR consortium. Seys SF, et al. J Allergy Clin Immunol. 2024 Oct 31:S0091-6749(24)01160-6. doi: 10.1016/j.jaci.2024.10.016. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39486595
Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP.
Bachert C, Khan AH, Fokkens WJ, Hopkins C, Gevaert P, Han JK, Hellings PW, Lee SE, Msihid J, Nash S, Sacks H, Jacob-Nara JA, Deniz Y, Rowe PJ. Bachert C, et al. Among authors: hopkins c. J Allergy Clin Immunol. 2024 Dec;154(6):1442-1449. doi: 10.1016/j.jaci.2024.07.026. Epub 2024 Aug 14. J Allergy Clin Immunol. 2024. PMID: 39151476 Free article. Clinical Trial.
Mild and symptom-free months in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab.
Bachert C, Khan AH, Hopkins C, Han JK, Fokkens WJ, Mannent LP, Msihid J, Borsos K, Kamat S, Nash S, Sacks H, Rowe PJ, Deniz Y, Jacob-Nara JA. Bachert C, et al. Among authors: hopkins c. Ann Allergy Asthma Immunol. 2024 Sep 28:S1081-1206(24)01535-7. doi: 10.1016/j.anai.2024.09.015. Online ahead of print. Ann Allergy Asthma Immunol. 2024. PMID: 39343385 Free article.
Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo-controlled OSTRO trial.
Emson C, Han JK, Hopkins C, Asimus S, Cann JA, Chain D, Wu Y, Reddy Y, McCrae C, Cohen D, Kreindler JL, Werkström V, Jison M, Wagenmann M, Bachert C. Emson C, et al. Among authors: hopkins c. Br J Clin Pharmacol. 2024 Aug;90(8):1952-1963. doi: 10.1111/bcp.16087. Epub 2024 May 7. Br J Clin Pharmacol. 2024. PMID: 38715387 Clinical Trial.
1,221 results